Developer docs
API playgroundTry for free, no card

Search company profiles

Kebotix

Full company profile

uuid00008ml

Namestring
Kebotix
Legal namestring
Kebotix, Inc.
Websiteurl
kebotix.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Kebotix is an AI-driven materials discovery company headquartered in Cambridge, Massachusetts, that operates what it describes as the world's first self-driving laboratory for chemicals and materials R&D. Founded in 2017 and publicly launched from The Engine accelerator in late 2018, the company integrates artificial intelligence, machine learning, physical modeling, and lab robotics into a closed-loop predict-produce-prove cycle designed to compress the time and cost of discovering novel specialty chemicals, polymers, pigments, coatings, OLED materials, and other functional materials that would otherwise require years of conventional bench-scale experimentation. The platform targets enterprise customers in chemicals, materials, pharmaceuticals, agriculture, energy, and government, with named engagements including Koura, Mitsubishi Chemical, Johnson Matthey, Valqua, Bayer, bp, NCATS, EPA, the University of Toronto, and Northeastern University.

The technology stack centers on three proprietary, trademarked products. ChemOS™ is an enterprise SaaS platform that orchestrates lab instruments, coordinates workflows, and applies active-learning algorithms to optimize synthesis and process chemistry. ReactionSage™ is an AI model that generates forward and retrosynthesis pathways beyond traditional rule-based systems, trained on large-scale reaction and patent-literature data. Automus™ is a digital platform that empowers lab researchers through closed-loop automated experimentation. The company also offers ChemOS Pro for advanced enterprise use cases and complete Materials Innovation Programs delivered through its self-driving lab. Integrations with third-party computational chemistry software, such as Netherlands-based SCM for density functional theory and molecular dynamics, extend the platform's reach.

Kebotix monetizes through a direct enterprise sales motion with custom, quote-based pricing and multi-year contracts, typically following a pilot → deployment → scaling arc. Customers access the technology through enterprise SaaS licensing of ChemOS™, standalone engagement of Automus™, or fully managed Materials Innovation Programs. The company has raised approximately $30 million cumulatively across a seed round, an $11.4 million Series A led by Novo Holdings in April 2020, a $15 million NSF partnership grant in 2021, and additional exempt offerings through 2024. Operations span four locations: Cambridge and Woburn, MA; Toronto, Canada (via wholly owned subsidiary Kebotix Canada); and Portland, ME (via a partnership with Northeastern University's Roux Institute). The management team is led by CEO and founder Jill S. Becker, with Chief Science Officer Semion Saikin, Chief Commercial Officer Christoph Kreisbeck, and Chief Visionary Officer Alán Aspuru-Guzik.

Short descriptiontext

Kebotix operates an AI-driven self-driving laboratory for chemicals and materials R&D, serving enterprise customers in chemicals, pharma, agriculture, energy, and government through its ChemOS, ReactionSage, and Automus platforms.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI materials discovery, self-driving lab, chemistry workflow automation, AI-driven R&D, molecular design platform
Industry3 codes
PRIMARYBPAEAHAF
AI/ML Engineering & Model Development Services
SECONDARYHDAAABAF
Model Deployment, Serving & Inference Platforms
Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/ML Platforms, MLOps & Model Lifecycle Management
SECONDARYAFABAIAI
Custom Synthesis & Technical Active Ingredient (AI) Manufacturing (intermediates, actives)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Agrochemical Formulation & Toll Manufacturing
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Analytical Laboratory Instrument Manufacturing334516
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Laboratory Analytical Instruments3826
  • Industrial Instruments For Measurement, Display, And Control3823
Product category
AI-powered materials discovery and computational chemistry software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Enterprise AI Solutions
TypeSubscription Recurring
Description

Provides technology access to digital R&D solutions including ChemOS™ and complete end-to-end materials innovation programs. Revenue generated through enterprise licensing and service contracts with major chemicals, materials, and manufacturing companies.

kebotix.com
2Materials Innovation Programs
TypeProfessional Services
Description

Complete materials innovation programs delivered to partners. Includes pilot phase, deployment phase, and scaling phase. Revenue from project-based engagements and long-term service agreements.

kebotix.com
3Software Licensing (ChemOS™)
TypeSubscription Recurring
Description

Enterprise SaaS solution for customers ready to bring their labs into the 21st century. ChemOS™ provided as software platform licensing.

kebotix.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales, Supply Chain
Pricing details1 tier
1Enterprise Solutions - Custom Pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based / Not publicly disclosed. Company uses enterprise sales approach with demo requests and custom engagement structures based on client needs.

kebotix.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1ChemOS
Description

Platform that integrates lab instruments, coordinates complete workflow, and collects data in AI-processable format for chemistry optimization.

kebotix.com
+2 more records
Core offering1 text field

Kebotix sells an enterprise AI platform for chemicals and materials discovery, delivered as the ChemOS™ SaaS workflow orchestration product and the ReactionSage™ reaction-pathway prediction tool, integrated with a proprietary closed-loop self-driving lab that combines cloud computing, machine learning, physical modeling, and lab automation. Customers license the software and/or engage Kebotix for full end-to-end materials innovation programs structured as pilot, deployment, and scaling phases. Target buyers are enterprise R&D organizations in chemicals, materials, pharmaceuticals, agriculture, and energy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Reduced experimental time from 49 hours to 9 hours (82% reduction) for NCATS collaboration
+4 more records
Product overview1 text field

Kebotix is a technology platform company offering a comprehensive suite of AI-powered tools for chemicals and materials discovery. The core offering consists of ChemOS™ (workflow orchestration and synthesis optimization), ReactionSage™ (AI-powered reaction pathway prediction), and Automus™ (digital platform for lab researchers). These products are delivered through a closed-loop self-driving lab architecture that integrates machine learning, physical modeling, and robotics automation. The platform enables rapid discovery of novel chemicals and materials by combining generative AI models for inverse design, active learning algorithms, and high-throughput virtual screening.

Product and service6 records
1ChemOS™
CategoryAI chemistry workflow orchestration software
Description

Enterprise SaaS platform that integrates lab instruments, orchestrates the complete chemistry workflow, and collects experimental data in AI-processable format to optimize chemical synthesis and process chemistry with active-learning-powered algorithms. Sold to enterprise chemicals and materials R&D organizations.

2ReactionSage™
CategoryAI synthesis planning software
Description

AI-driven reaction pathway prediction tool that uses deep learning over millions of reactions to suggest novel and diverse forward and retro synthesis routes beyond traditional rule-based expert systems. Marketed to chemists and enterprise R&D groups in chemicals and pharmaceuticals.

3Automus™
CategoryDigital R&D productivity platform
Description

Digital platform that empowers lab researchers and increases R&D productivity by automating the scientific method using Kebotix's proprietary closed-loop process to predict and produce new chemistries.

4ChemOS Pro
CategoryEnterprise AI software platform
Description

Enterprise-tier version of ChemOS that develops machine learning models via proprietary active learning optimization algorithms for advanced materials discovery applications. Used with enterprise customers such as Johnson Matthey for catalytic converter coating optimization.

5Enterprise AI Solutions (digital R&D solutions)
CategoryAI digital R&D solution suite
Description

Bundle of AI-powered digital R&D capabilities including materials informatics, computational modeling, formulation and process optimization, and inverse molecular and material design, sold to enterprise R&D organizations in chemicals, materials, and manufacturing.

6Materials Innovation Programs
CategoryCustom materials innovation services
Description

End-to-end materials innovation programs delivered to enterprise partners through pilot, deployment, and scaling phases, producing novel materials candidates tailored to specific customer applications such as coatings, polymers, OLED emitters, and crop protection molecules.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership for discovery of environmentally friendly high-performance materials. Discovered materials in 3 months instead of typical 3+ years at significant cost reduction. Koura is a major global provider of products and solutions across multiple industrial sectors.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration to deliver new treatments and cures for diseases faster. AI-driven optimization of assay conditions for biosynthesis inhibitors reduced experimental time from 49 hours to 9 hours.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Testing AI tools for designing new molecules and materials. Collaboration explored how AI and digital technologies can shorten design process. Project ran August 2019 to May 2020.

4Mitsubishi Chemical Corporation
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to tackle toxicity by discovering substitute for Bisphenol A (BPA). MCC selected Kebotix to expand long-standing effort to solve environmental problems with greener chemistry.

kebotix.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Catalytic converter optimization project using ChemOS™ Pro technology. Project to discover innovative methods to increase efficiency of experiments for coating formulations optimization. Supports JM's digital strategy.

6Valqua
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Three-year deal to transform Valqua's R&D process. After successful 6-month POC, partnership expanded to new material development program for sealing products and high-performance plastics. Reduced testing protocol times by up to 50%.

kebotix.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration to speed delivery of agricultural innovations and crop protection solutions. Kebotix AI accelerates synthesis of new molecules within Bayer's Crop Science R&D program for faster delivery to farmers worldwide.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to evaluate new class of OLED molecules developed and patented by the university. Kebotix's closed-loop innovation platform accelerates time-to-market for next-generation OLED emitters.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

SBIR funding to develop safe diarylide pigment alternatives. Program uses machine-learning platform to develop pigments that do not produce PCBs and other toxic byproducts.

Strategic tierCoreTypeTechnology or Integration
Description

Strategic partnership with Netherlands-based computational chemistry software company. Integrates atomistic simulations with AI-driven workflows. Combines SCM's density functional theory and molecular dynamics with Kebotix's machine learning techniques.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Industry partner of $15-million Institute for Data Driven Dynamical Design (ID4) funded by NSF. Kebotix collaborates with 11 universities including Harvard, Northwestern, Princeton to harness data for accelerated materials discovery.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to establish office and research footprint in Maine. Enables talent pipeline across region and collaboration with world-class academic researchers. Second collaboration with Northeastern after cancer research project.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Chemistry-focused accelerator in Woburn, MA where Kebotix established its second research lab. 1,000 square feet facility with experienced organic chemistry team led by Raj Rajur.

14MIT Startup Exchange
Strategic tierMinorTypeGTM or Marketing Partner
Description

Partnership through MIT's ecosystem for corporate partnerships. Connected Kebotix with Valqua at MIT Japan Conference in Tokyo.

kebotix.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Green chemistry pioneer joins as advisor on innovation, sustainability and green chemistry. Will integrate 12 Principles of Green Chemistry into Kebotix's AI/ML methods. Co-author of defining text 'Green Chemistry: Theory and Practice'.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AI platform purpose-built for materials and chemicals discovery, ingesting materials data to accelerate R&D for enterprise customers. Directly comparable to Kebotix in target market (chemicals/materials enterprises), AI-driven materials informatics offering, and SaaS-plus-services revenue model.

TypeBroad incumbent
Description

Public computational chemistry platform serving pharma and materials science with physics-based simulation and ML. Overlaps Kebotix in AI-for-materials but is a much broader, more established player spanning drug discovery and materials simulation.

TypeDirect peer
Description

AI-driven drug discovery company that combines high-throughput wet-lab experimentation with ML in a closed-loop "labs in a loop" model. Highly comparable to Kebotix's self-driving lab paradigm and predict-produce-prove workflow, applied to life sciences.

TypeDirect peer
Description

Uses AI for small-molecule design and discovery, partnering with pharma and crop science companies (Bayer among its collaborators). Directly comparable in AI-driven molecular design, pharma/agro customer overlap, and partnership-driven commercial model.

TypeDirect peer
Description

AI-driven drug discovery platform combining generative chemistry, predictive modeling and automation. Comparable in AI-for-chemistry focus and enterprise pharma partnerships, with overlapping capability in generative molecular design.

6Iambic Therapeutics
TypeEmerging player
Description

Early-stage AI-driven drug discovery company building generative chemistry models and automated experimentation infrastructure. Comparable in AI-for-chemistry focus and closed-loop experimentation ethos, though focused on therapeutics rather than industrial materials.

TypeBroad incumbent
Description

Scientific R&D informatics platform used across chemicals, materials and life sciences to manage lab data and workflows. Comparable as an enterprise SaaS platform serving similar chemicals/materials R&D customers, but broader in scope and not AI-native for materials discovery.

TypeBroad incumbent
Description

Cloud platform for biotech R&D, including lab notebooks, registries and workflow tools. Serves similar enterprise R&D customers in life sciences but is a horizontal lab informatics platform rather than an AI-driven materials discovery stack.

TypeBroad incumbent
Description

Scientific software suite from Dassault Systèmes covering molecular modeling, materials simulation and lab informatics. Comparable in serving materials/chemicals R&D customers with computational tools, but as part of a much larger, established enterprise software portfolio.

TypeBroad incumbent
Description

Industrial software platform for process industries including chemicals and energy, with growing asset/AI capabilities. Compares on enterprise customers (bp-style energy and chemical majors) but focuses on plant operations rather than lab-stage materials discovery.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors13 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Kebotix

AI-powered materials discovery and computational chemistry softwarekebotix.com

Kebotix operates an AI-driven self-driving laboratory for chemicals and materials R&D, serving enterprise customers in chemicals, pharma, agriculture, energy, and government through its ChemOS, ReactionSage, and Automus platforms.

What Kebotix does

Kebotix is an AI-driven materials discovery company headquartered in Cambridge, Massachusetts, that operates what it describes as the world's first self-driving laboratory for chemicals and materials R&D. Founded in 2017 and publicly launched from The Engine accelerator in late 2018, the company integrates artificial intelligence, machine learning, physical modeling, and lab robotics into a closed-loop predict-produce-prove cycle designed to compress the time and cost of discovering novel specialty chemicals, polymers, pigments, coatings, OLED materials, and other functional materials that would otherwise require years of conventional bench-scale experimentation. The platform targets enterprise customers in chemicals, materials, pharmaceuticals, agriculture, energy, and government, with named engagements including Koura, Mitsubishi Chemical, Johnson Matthey, Valqua, Bayer, bp, NCATS, EPA, the University of Toronto, and Northeastern University.

The technology stack centers on three proprietary, trademarked products. ChemOS™ is an enterprise SaaS platform that orchestrates lab instruments, coordinates workflows, and applies active-learning algorithms to optimize synthesis and process chemistry. ReactionSage™ is an AI model that generates forward and retrosynthesis pathways beyond traditional rule-based systems, trained on large-scale reaction and patent-literature data. Automus™ is a digital platform that empowers lab researchers through closed-loop automated experimentation. The company also offers ChemOS Pro for advanced enterprise use cases and complete Materials Innovation Programs delivered through its self-driving lab. Integrations with third-party computational chemistry software, such as Netherlands-based SCM for density functional theory and molecular dynamics, extend the platform's reach.

Kebotix monetizes through a direct enterprise sales motion with custom, quote-based pricing and multi-year contracts, typically following a pilot → deployment → scaling arc. Customers access the technology through enterprise SaaS licensing of ChemOS™, standalone engagement of Automus™, or fully managed Materials Innovation Programs. The company has raised approximately $30 million cumulatively across a seed round, an $11.4 million Series A led by Novo Holdings in April 2020, a $15 million NSF partnership grant in 2021, and additional exempt offerings through 2024. Operations span four locations: Cambridge and Woburn, MA; Toronto, Canada (via wholly owned subsidiary Kebotix Canada); and Portland, ME (via a partnership with Northeastern University's Roux Institute). The management team is led by CEO and founder Jill S. Becker, with Chief Science Officer Semion Saikin, Chief Commercial Officer Christoph Kreisbeck, and Chief Visionary Officer Alán Aspuru-Guzik.

Kebotix firmographics

Firmographics
Name
Kebotix
Legal name
Kebotix, Inc.
Website
https://kebotix.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
Kebotix operates an AI-driven self-driving laboratory for chemicals and materials R&D, serving enterprise customers in chemicals, pharma, agriculture, energy, and government through its ChemOS, ReactionSage, and Automus platforms.
Ownership category
akta.pro rank

Kebotix industry classification

Industry
Product category
AI-powered materials discovery and computational chemistry software
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826), Industrial Instruments For Measurement, Display, And Control (3823)
akta.pro industry
PRIMARYBPAEAHAF
AI/ML Engineering & Model Development Services
SECONDARYHDAAABAF
Model Deployment, Serving & Inference Platforms
Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/ML Platforms, MLOps & Model Lifecycle Management
SECONDARYAFABAIAI
Custom Synthesis & Technical Active Ingredient (AI) Manufacturing (intermediates, actives)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Agrochemical Formulation & Toll Manufacturing

Keywords

  • AI materials discovery
  • Self-driving lab
  • Chemistry workflow automation
  • AI-driven R&D
  • Molecular design platform

Where Kebotix is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Kebotix business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Enterprise AI Solutions: Provides technology access to digital R&D solutions including ChemOS™ and complete end-to-end materials innovation programs. Revenue generated through enterprise licensing and service contracts with major chemicals, materials, and manufacturing companies.
  2. Materials Innovation Programs: Complete materials innovation programs delivered to partners. Includes pilot phase, deployment phase, and scaling phase. Revenue from project-based engagements and long-term service agreements.
  3. Software Licensing (ChemOS™): Enterprise SaaS solution for customers ready to bring their labs into the 21st century. ChemOS™ provided as software platform licensing.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise Solutions - Custom Pricing

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Kebotix product offering

Product offering

Core offering

Kebotix sells an enterprise AI platform for chemicals and materials discovery, delivered as the ChemOS™ SaaS workflow orchestration product and the ReactionSage™ reaction-pathway prediction tool, integrated with a proprietary closed-loop self-driving lab that combines cloud computing, machine learning, physical modeling, and lab automation. Customers license the software and/or engage Kebotix for full end-to-end materials innovation programs structured as pilot, deployment, and scaling phases. Target buyers are enterprise R&D organizations in chemicals, materials, pharmaceuticals, agriculture, and energy.

Product overview

Kebotix is a technology platform company offering a comprehensive suite of AI-powered tools for chemicals and materials discovery. The core offering consists of ChemOS™ (workflow orchestration and synthesis optimization), ReactionSage™ (AI-powered reaction pathway prediction), and Automus™ (digital platform for lab researchers). These products are delivered through a closed-loop self-driving lab architecture that integrates machine learning, physical modeling, and robotics automation. The platform enables rapid discovery of novel chemicals and materials by combining generative AI models for inverse design, active learning algorithms, and high-throughput virtual screening.

Differentiator

Problem solved

Functional benefit

Brands

  • ChemOS: Platform that integrates lab instruments, coordinates complete workflow, and collects data in AI-processable format for chemistry optimization.
  • ReactionSage
  • Automus

Products and services

  • ChemOS™ Enterprise SaaS platform that integrates lab instruments, orchestrates the complete chemistry workflow, and collects experimental data in AI-processable format to optimize chemical synthesis and process chemistry with active-learning-powered algorithms. Sold to enterprise chemicals and materials R&D organizations.
  • ReactionSage™ AI-driven reaction pathway prediction tool that uses deep learning over millions of reactions to suggest novel and diverse forward and retro synthesis routes beyond traditional rule-based expert systems. Marketed to chemists and enterprise R&D groups in chemicals and pharmaceuticals.
  • Automus™ Digital platform that empowers lab researchers and increases R&D productivity by automating the scientific method using Kebotix's proprietary closed-loop process to predict and produce new chemistries.
  • ChemOS Pro Enterprise-tier version of ChemOS that develops machine learning models via proprietary active learning optimization algorithms for advanced materials discovery applications. Used with enterprise customers such as Johnson Matthey for catalytic converter coating optimization.
  • Enterprise AI Solutions (digital R&D solutions) Bundle of AI-powered digital R&D capabilities including materials informatics, computational modeling, formulation and process optimization, and inverse molecular and material design, sold to enterprise R&D organizations in chemicals, materials, and manufacturing.
  • Materials Innovation Programs End-to-end materials innovation programs delivered to enterprise partners through pilot, deployment, and scaling phases, producing novel materials candidates tailored to specific customer applications such as coatings, polymers, OLED emitters, and crop protection molecules.

Quantifiable outcome

  • Reduced experimental time from 49 hours to 9 hours (82% reduction) for NCATS collaboration
  • +4 more outcomes

Companies that use Kebotix

Customer profile

Named customers10 records

Segments5 records

Ideal customer profiles4 records

Kebotix technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature8 records

Kebotix partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered core, flagship and minor.

  • Koura (formerly Mexichem Fluor)coreStrategic or Co-development PartnerPartnership for discovery of environmentally friendly high-performance materials. Discovered materials in 3 months instead of typical 3+ years at significant cost reduction. Koura is a major global provider of products and solutions across multiple industrial sectors.
  • NCATS (National Center for Advancing Translational Sciences)coreStrategic or Co-development PartnerCollaboration to deliver new treatments and cures for diseases faster. AI-driven optimization of assay conditions for biosynthesis inhibitors reduced experimental time from 49 hours to 9 hours.
  • bpcoreStrategic or Co-development PartnerTesting AI tools for designing new molecules and materials. Collaboration explored how AI and digital technologies can shorten design process. Project ran August 2019 to May 2020.
  • Mitsubishi Chemical CorporationcoreStrategic or Co-development PartnerPartnership to tackle toxicity by discovering substitute for Bisphenol A (BPA). MCC selected Kebotix to expand long-standing effort to solve environmental problems with greener chemistry.
  • Johnson MattheycoreStrategic or Co-development PartnerCatalytic converter optimization project using ChemOS™ Pro technology. Project to discover innovative methods to increase efficiency of experiments for coating formulations optimization. Supports JM's digital strategy.
  • ValquacoreStrategic or Co-development PartnerThree-year deal to transform Valqua's R&D process. After successful 6-month POC, partnership expanded to new material development program for sealing products and high-performance plastics. Reduced testing protocol times by up to 50%.
  • BayercoreStrategic or Co-development PartnerCollaboration to speed delivery of agricultural innovations and crop protection solutions. Kebotix AI accelerates synthesis of new molecules within Bayer's Crop Science R&D program for faster delivery to farmers worldwide.
  • University of TorontocoreStrategic or Co-development PartnerPartnership to evaluate new class of OLED molecules developed and patented by the university. Kebotix's closed-loop innovation platform accelerates time-to-market for next-generation OLED emitters.
  • EPA (Environmental Protection Agency)coreStrategic or Co-development PartnerSBIR funding to develop safe diarylide pigment alternatives. Program uses machine-learning platform to develop pigments that do not produce PCBs and other toxic byproducts.
  • SCM (Software for Chemistry & Materials)coreTechnology or IntegrationStrategic partnership with Netherlands-based computational chemistry software company. Integrates atomistic simulations with AI-driven workflows. Combines SCM's density functional theory and molecular dynamics with Kebotix's machine learning techniques.
  • Colorado School of MinesflagshipStrategic or Co-development PartnerIndustry partner of $15-million Institute for Data Driven Dynamical Design (ID4) funded by NSF. Kebotix collaborates with 11 universities including Harvard, Northwestern, Princeton to harness data for accelerated materials discovery.
  • Northeastern University's Roux InstitutecoreStrategic or Co-development PartnerPartnership to establish office and research footprint in Maine. Enables talent pipeline across region and collaboration with world-class academic researchers. Second collaboration with Northeastern after cancer research project.
  • C2I (Creagen Incubator)minorStrategic or Co-development PartnerChemistry-focused accelerator in Woburn, MA where Kebotix established its second research lab. 1,000 square feet facility with experienced organic chemistry team led by Raj Rajur.
  • MIT Startup ExchangeminorGTM or Marketing PartnerPartnership through MIT's ecosystem for corporate partnerships. Connected Kebotix with Valqua at MIT Japan Conference in Tokyo.
  • John Warner (Advisor)coreStrategic or Co-development PartnerGreen chemistry pioneer joins as advisor on innovation, sustainability and green chemistry. Will integrate 12 Principles of Green Chemistry into Kebotix's AI/ML methods. Co-author of defining text 'Green Chemistry: Theory and Practice'.

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

Kebotix competitors and assessment

Company assessment

Direct peers

  • Citrine Informatics: AI platform purpose-built for materials and chemicals discovery, ingesting materials data to accelerate R&D for enterprise customers. Directly comparable to Kebotix in target market (chemicals/materials enterprises), AI-driven materials informatics offering, and SaaS-plus-services revenue model.
  • Recursion Pharmaceuticals: AI-driven drug discovery company that combines high-throughput wet-lab experimentation with ML in a closed-loop "labs in a loop" model. Highly comparable to Kebotix's self-driving lab paradigm and predict-produce-prove workflow, applied to life sciences.
  • Atomwise: Uses AI for small-molecule design and discovery, partnering with pharma and crop science companies (Bayer among its collaborators). Directly comparable in AI-driven molecular design, pharma/agro customer overlap, and partnership-driven commercial model.
  • InSilico Medicine: AI-driven drug discovery platform combining generative chemistry, predictive modeling and automation. Comparable in AI-for-chemistry focus and enterprise pharma partnerships, with overlapping capability in generative molecular design.

Broad incumbents

  • Schrödinger: Public computational chemistry platform serving pharma and materials science with physics-based simulation and ML. Overlaps Kebotix in AI-for-materials but is a much broader, more established player spanning drug discovery and materials simulation.
  • Dotmatics: Scientific R&D informatics platform used across chemicals, materials and life sciences to manage lab data and workflows. Comparable as an enterprise SaaS platform serving similar chemicals/materials R&D customers, but broader in scope and not AI-native for materials discovery.
  • Benchling: Cloud platform for biotech R&D, including lab notebooks, registries and workflow tools. Serves similar enterprise R&D customers in life sciences but is a horizontal lab informatics platform rather than an AI-driven materials discovery stack.
  • BIOVIA (Dassault Systèmes): Scientific software suite from Dassault Systèmes covering molecular modeling, materials simulation and lab informatics. Comparable in serving materials/chemicals R&D customers with computational tools, but as part of a much larger, established enterprise software portfolio.
  • Aspen Technology: Industrial software platform for process industries including chemicals and energy, with growing asset/AI capabilities. Compares on enterprise customers (bp-style energy and chemical majors) but focuses on plant operations rather than lab-stage materials discovery.

Emerging players

  • Iambic Therapeutics: Early-stage AI-driven drug discovery company building generative chemistry models and automated experimentation infrastructure. Comparable in AI-for-chemistry focus and closed-loop experimentation ethos, though focused on therapeutics rather than industrial materials.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Kebotix social profiles

Digital presence

Kebotix financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Kebotix leadership team

Management profile

Number of profiles

Profiles5 records

Kebotix subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Kebotix funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Kebotix M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kebotix

What does Kebotix do?

Kebotix sells an enterprise AI platform for chemicals and materials discovery, delivered as the ChemOS™ SaaS workflow orchestration product and the ReactionSage™ reaction-pathway prediction tool, integrated with a proprietary closed-loop self-driving lab that combines cloud computing, machine learning, physical modeling, and lab automation. Customers license the software and/or engage Kebotix for full end-to-end materials innovation programs structured as pilot, deployment, and scaling phases. Target buyers are enterprise R&D organizations in chemicals, materials, pharmaceuticals, agriculture, and energy.

Is Kebotix a public or private company?

Kebotix is a private company. It is classified as venture growth investor backed and is currently operating.

When was Kebotix founded?

Kebotix was founded in 2018. It employs 1 to 10 people.

Where is Kebotix based?

Kebotix is headquartered in Cambridge, United States, in the North America region.

How does Kebotix make money?

Three revenue lines are on record. Enterprise AI Solutions are the primary driver. The others are materials Innovation Programs and software Licensing (ChemOS™).

Who are Kebotix's main competitors?

Direct peers on record are Citrine Informatics, Recursion Pharmaceuticals, Atomwise and InSilico Medicine. Broad incumbents are Schrödinger, Dotmatics, Benchling, BIOVIA (Dassault Systèmes) and Aspen Technology. Iambic Therapeutics is listed as an emerging player.

Does Kebotix have an API?

No public API is recorded for Kebotix.

What industry is Kebotix in?

Kebotix's product category is AI-powered materials discovery and computational chemistry software. Its primary akta.pro industry code is BPAEAHAF, AI/ML Engineering & Model Development Services, with a secondary code of HDAAABAF, Model Deployment, Serving & Inference Platforms. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SecSEC FORM DKebotix, Inc. filed a Form D with the SEC for an exempt offering of equity securities under Rule 506(b), with total proceeds capped at approximately $10 million. The filing indicates that $4.99 million has been sold to ten investors as of July 22, 2024, with the remaining amount available for sale.SecSEC FORM DKebotix, Inc. filed a Form D with the Securities and Exchange Commission to report an exempt offering of securities under Regulation D Rule 506(b). The company has raised $2,209,999 USD out of a total offering amount of $3,999,999 USD from 11 investors as of March 29, 2023. This filing discloses the strategic capital raising activity undertaken by the Cambridge-based biotechnology firm.PR NewswireDeploying materials informatics: IDTechEx Discusses if SaaS Is a One-Size-Fits-All ApproachIDTechEx's report on materials informatics (MI) examines whether SaaS platforms are the optimal approach for companies seeking to integrate machine learning into materials R&D, finding that while SaaS lowers skill barriers and accelerates adoption, major players like 3M and Hitachi prefer building internal capabilities for greater differentiation. The market for external MI services is projected to grow at 13.7% CAGR by 2033, with some providers like Kebotix pivoting from pure SaaS toward generating their own materials IP, while others like OTI Lumionics raised US$55M in October 2022 pursuing alternative approaches.PR NewswireKebotix Tapped by EPA to Develop Safe PigmentsThe U.S. Environmental Protection Agency awarded Kebotix funding through its Small Business Innovation Research Program to develop safe alternatives to diarylide pigments, which currently produce toxic polychlorinated biphenyls during manufacturing. The Cambridge, Massachusetts-based AI company will use its machine learning and robotics platform to discover halogen- and heavy metal-free pigments, targeting a global market that produces over 50,000 tons of diarylide yellows annually. The EPA funding is expected to reduce pigment design costs and accelerate scaled-up production of safer color technologies.PR NewswireKebotix, SCM Partner to Advance Materials InnovationKebotix, a U.S.-based technology platform company, and SCM, a Netherlands-based software company, announced a strategic partnership to integrate their technologies for advanced materials discovery. The collaboration aims to enable faster and more cost-effective development of new chemicals and materials using AI and atomistic simulations.edge insights and analysisKebotix on Cusp of ‘Promising’ OLED BreakthroughKebotix is developing next-generation OLED emitter molecules using its proprietary AI-powered platform, aiming to address industry challenges such as low yield and high costs. The company plans to have these candidate molecules ready for testing with manufacturing partners in early to mid-2022. These materials are designed to be compatible with solution-processing technologies like printing, potentially expanding OLED applications into smart packaging and wearable sensors.PR NewswireKebotix on Cusp of 'Promising' OLED BreakthroughKebotix, a Cambridge, Massachusetts-based AI-powered materials discovery company founded in 2017, has developed a pipeline for smart design of OLED emitter molecules using a proprietary closed-loop innovation platform spawned by a Department of Energy Small Business Innovation Research grant. In less than six months, the company discovered several new classes of candidate molecules and developed them into device prototypes, generating dozens of candidates from a pool of 20 million on a weekly basis. Kebotix is targeting early-to mid-2022 to test these molecules with manufacturing partners as early adopters of next-generation OLED technology.PR NewswireKebotix, Mitsubishi Chemical Join Forces in Tackling ToxicityMitsubishi Chemical Corporation has selected Kebotix, a U.S.-based AI and robotics platform for chemicals and materials discovery, to collaborate on finding a substitute for Bisphenol A (BPA), a toxic chemical widely used in polycarbonate plastics and epoxy resins. Kebotix will use computational and machine learning models combined with experimental testing to screen millions of molecular designs and identify candidate substances for BPA replacement. The collaboration is part of Mitsubishi Chemical's broader sustainability initiative to address environmental problems through greener chemistry while maintaining product diversity.